These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32145655)

  • 1. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
    Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
    J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
    Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
    Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program.
    Fugit RV; McCoury JB; Bessesen MT
    Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S49-S54. PubMed ID: 36371732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
    Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
    Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
    Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.